University of California San Francisco
<p>UCSF Benioff Children’s Hospital’s Division of General Pediatrics has developed a large collection of pediatric clinical trials, which are now readily accessible via a new website that features the latest news and information on UCSF’s general clinical trials with children. </p>
<p>Chancellor Susan Desmond-Hellmann, MD, MPH, will share a glimpse of UCSF’s future on Tuesday, Oct. 4 when she delivers the State of the University address.</p>
Olympians and swimming enthusiasts will take part in Swim Across America’s (SAA) sixth annual San Francisco Bay Area Open Water Swim.
<p>UCSF surgeons at the Institute for Global Orthopaedics & Traumatology hosted a symposium designed to provide hands-on training in trauma care to physicians from around the world.</p>
<p>For two days, the UCSF School of Nursing faculty and staff pondered its long term future, sketching the beginnings of an ambitious blueprint to guide the nursing program over the next five years.</p>
<p>The UCSF community is invited to hear JudyAnn Bigby talk about "The Massachusetts Health Reform Experience" during the Chancellor's Health Policy Lecture on September 26.</p>
Frontotemporal dementia and amyotrophic lateral sclerosis, also known as Lou Gehrig’s disease -- two fatal neurodegenerative disease with distinct symptoms -- are triggered by a common mutation in many cases, according to researchers who say they have identified the mutated gene.
<p>UCSF neurologist William Seeley, MD, has been named a 2011 MacArthur Fellow, one of the highest honors bestowed on an individual in the United States.</p>
<p>Three UCSF researchers have been named among the 2011 recipients of the National Institutes of Health (NIH) Director's New Innovator Awards, one of the most competitively sought-after sources of research funding made available to young academic scientists through the NIH.</p>
<p>Faculty are encouraged to apply for the <a href="https://innovation.ucsf.edu/venture/catalyst-program">T1 Translational Catalyst Award</a>, which is designed to help drive promising, early-stage research through the lengthy and complex process of bringing products and procedures to patients.</p>
A UCSF study holds clues to why an emerging clinical trials option for heart attack patients has not been as successful as anticipated. Treatment of human hearts with bone marrow cells has led to limited to no success in improving their heart function even though a similar method has been much more effective in rodents.